{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:26:05Z","timestamp":1761675965767},"reference-count":119,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.neuropharm.2012.08.010","type":"journal-article","created":{"date-parts":[[2012,8,23]],"date-time":"2012-08-23T18:46:10Z","timestamp":1345747570000},"page":"106-115","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Rett syndrome treatment in mouse models: Searching for effective targets and strategies"],"prefix":"10.1016","volume":"68","author":[{"given":"Laura","family":"Ricceri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca","family":"De Filippis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Laviola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2012.08.010_bib1","doi-asserted-by":"crossref","first-page":"18208","DOI":"10.1073\/pnas.1012104107","article-title":"Correction of respiratory disorders in a mouse model of Rett syndrome","volume":"107","author":"Abdala","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.08.010_bib2","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1523\/JNEUROSCI.4225-08.2009","article-title":"MeCP2-mediated transcription repression in the basolateral amygdala may underlie heightened anxiety in a mouse model of Rett syndrome","volume":"29","author":"Adachi","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/13810","article-title":"Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2","volume":"23","author":"Amir","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ajhg.2008.05.015","article-title":"FOXG1 is responsible for the congenital variant of Rett syndrome","volume":"83","author":"Ariani","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.nbd.2005.07.005","article-title":"Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome","volume":"21","author":"Asaka","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib6","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nn.2275","article-title":"Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology","volume":"12","author":"Ballas","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib7","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1203\/01.pdr.0000203157.31924.4a","article-title":"Separate respiratory phenotypes in methyl-CpG-binding protein 2 (Mecp2) deficient mice","volume":"59","author":"Bissonnette","year":"2006","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib8","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1002\/ar.21380","article-title":"Temporal and regional alterations in NMDA receptor expression in Mecp2-null mice","volume":"294","author":"Blue","year":"2011","journal-title":"Anat. Rec. (Hoboken)"},{"key":"10.1016\/j.neuropharm.2012.08.010_bib9","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/1531-8249(199904)45:4<541::AID-ANA21>3.0.CO;2-2","article-title":"Development of amino acid receptors in frontal cortex from girls with Rett syndrome","volume":"45","author":"Blue","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib10","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/syn.21515","article-title":"Correlation of the vesicular acetylcholine transporter densities in the striata to the clinical abilities of women with Rett syndrome","volume":"66","author":"Brasic","year":"2012","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2012.08.010_bib11","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/hmg\/ddr602","article-title":"Pharmacological interference with the glucocorticoid system influences symptoms and lifespan in a mouse model of Rett syndrome","volume":"21","author":"Braun","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib12","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1203\/PDR.0b013e31819d9ebc","article-title":"Suppression of nonsense mutations in Rett syndrome by aminoglycoside antibiotics","volume":"65","author":"Brendel","year":"2009","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1258\/ebm.2010.010261","article-title":"Experimental models of Rett syndrome based on Mecp2 dysfunction","volume":"236","author":"Calfa","year":"2011","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.neuropharm.2012.08.010_bib14","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.neubiorev.2010.10.017","article-title":"Maternal corticosterone effects on hypothalamus-pituitary-adrenal axis regulation and behavior of the offspring in rodents","volume":"35","author":"Catalani","year":"2011","journal-title":"Neurosci. Biobehav Rev."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib15","doi-asserted-by":"crossref","first-page":"15163","DOI":"10.1523\/JNEUROSCI.2617-11.2011","article-title":"Activation of Rho GTPases triggers structural remodeling and functional plasticity in the adult rat visual cortex","volume":"31","author":"Cerri","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.gde.2007.02.003","article-title":"MeCP2 in Rett syndrome: transcriptional repressor or chromatin architectural protein?","volume":"17","author":"Chadwick","year":"2007","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib17","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1126\/science.1153252","article-title":"MeCP2, a key contributor to neurological disease, activates and represses transcription","volume":"320","author":"Chahrour","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2012.08.010_bib18","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.neuron.2007.10.001","article-title":"The story of Rett syndrome: from clinic to neurobiology","volume":"56","author":"Chahrour","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2012.08.010_bib19","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.neuron.2005.12.027","article-title":"The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression","volume":"49","author":"Chang","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2012.08.010_bib20","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nature09582","article-title":"Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes","volume":"468","author":"Chao","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.08.010_bib21","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/85906","article-title":"Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice","volume":"27","author":"Chen","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib22","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1126\/science.1086446","article-title":"Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2","volume":"302","author":"Chen","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2012.08.010_bib23","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neuron.2011.08.022","article-title":"Genome-wide activity-dependent MeCP2 phosphorylation regulates nervous system development and function","volume":"72","author":"Cohen","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2012.08.010_bib24","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1093\/hmg\/ddh282","article-title":"Mild overexpression of MeCP2 causes a progressive neurological disorder in mice","volume":"13","author":"Collins","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib25","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1091\/mbc.11.5.1775","article-title":"The p21 Rho-activating toxin cytotoxic necrotizing factor 1 is endocytosed by a clathrin-independent mechanism and enters the cytosol by an acidic-dependent membrane translocation step","volume":"11","author":"Contamin","year":"2000","journal-title":"Mol. Biol. Cell."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib26","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/mrdd.20039","article-title":"Designing mouse behavioral tasks relevant to autistic-like behaviors","volume":"10","author":"Crawley","year":"2004","journal-title":"Ment. Retard. Dev. Disabil. Res. Rev."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib27","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1750-3639.2007.00096.x","article-title":"Mouse behavioral assays relevant to the symptoms of autism","volume":"17","author":"Crawley","year":"2007","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib28","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1523\/JNEUROSCI.5841-11.2012","article-title":"Isoform-specific toxicity of Mecp2 in postmitotic neurons: suppression of neurotoxicity by FoxG1","volume":"32","author":"Dastidar","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib29","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/npp.2011.301","article-title":"Modulation of RhoGTPases improves the behavioral phenotype and reverses astrocytic deficits in a mouse model of Rett syndrome","volume":"37","author":"De Filippis","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.08.010_bib30","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.neuropharm.2012.05.048","article-title":"Neonatal exposure to low dose corticosterone persistently modulates hippocampal mineralocorticoid receptor expression and improves locomotor\/exploratory behaviour in a mouse model of Rett syndrome","volume":"68","author":"De Filippis","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.08.010_bib31","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1601-183X.2009.00551.x","article-title":"Early postnatal behavioral changes in the Mecp2-308 truncation mouse model of Rett syndrome","volume":"9","author":"De Filippis","year":"2010","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib32","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1111\/j.1460-9568.2011.07658.x","article-title":"In sickness and in health: the role of methyl-CpG binding protein 2 in the central nervous system","volume":"33","author":"de Leon-Guerrero","year":"2011","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib33","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bbr.2010.03.049","article-title":"The Rho GTPase activating CNF1 improves associative working memory for object-in-place","volume":"212","author":"De Viti","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature10907","article-title":"Wild-type microglia arrest pathology in a mouse model of Rett syndrome","volume":"484","author":"Derecki","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.08.010_bib35","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1073\/pnas.0610059104","article-title":"Enhancement of learning and memory after activation of cerebral Rho GTPases","volume":"104","author":"Diana","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"Suppl 1","key":"10.1016\/j.neuropharm.2012.08.010_bib36","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/j.braindev.2005.03.014","article-title":"Abnormal general movements in girls with Rett disorder: the first four months of life","volume":"27","author":"Einspieler","year":"2005","journal-title":"Brain Dev."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib37","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1177\/08830738050200090501","article-title":"MECP2 abnormality phenotypes: clinicopathologic area with broad variability","volume":"20","author":"Erlandson","year":"2005","journal-title":"J.\u00a0Child. Neurol."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib38","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nature01148","article-title":"Rho GTPases in cell biology","volume":"420","author":"Etienne-Manneville","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.08.010_bib39","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.neuron.2008.07.030","article-title":"Deletion of Mecp2 in Sim1-expressing neurons reveals a critical role for MeCP2 in feeding behavior, aggression, and the response to stress","volume":"59","author":"Fyffe","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2012.08.010_bib40","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.biopsych.2005.07.025","article-title":"Postnatal loss of methyl-CpG binding protein 2 in the forebrain is sufficient to mediate behavioral aspects of Rett syndrome in mice","volume":"59","author":"Gemelli","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.08.010_bib41","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1073\/pnas.0610593104","article-title":"Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2","volume":"104","author":"Giacometti","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.08.010_bib42","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nn.2997","article-title":"Rett syndrome mutation MeCP2 T158A disrupts DNA binding, protein stability and ERP responses","volume":"15","author":"Goffin","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/gad.1256405","article-title":"The role of the Rho GTPases in neuronal development","volume":"19","author":"Govek","year":"2005","journal-title":"Genes Dev."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib44","doi-asserted-by":"crossref","first-page":"RC195","DOI":"10.1523\/JNEUROSCI.22-01-j0005.2002","article-title":"Prenatal choline supplementation protects against postnatal neurotoxicity","volume":"22","author":"Guo-Ross","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib45","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1146\/annurev-cellbio-092910-154121","article-title":"The role of MeCP2 in the brain","volume":"27","author":"Guy","year":"2011","journal-title":"Annu. Rev. Cell. Dev. Biol."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib46","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1126\/science.1138389","article-title":"Reversal of neurological defects in a mouse model of Rett syndrome","volume":"315","author":"Guy","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2012.08.010_bib47","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/85899","article-title":"A\u00a0mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome","volume":"27","author":"Guy","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib48","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/mrdd.10020","article-title":"Clinical manifestations and stages of Rett syndrome","volume":"8","author":"Hagberg","year":"2002","journal-title":"Ment. Retard. Dev. Disabil. Res. Rev."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib49","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ana.410140412","article-title":"A\u00a0progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases","volume":"14","author":"Hagberg","year":"1983","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib50","doi-asserted-by":"crossref","unstructured":"Hagberg, B., Hanefeld, F., Percy, A., Skjeldal, O., 2002. An update on clinically applicable diagnostic criteria in Rett syndrome. Comments to Rett syndrome Clinical Criteria Consensus Panel Satellite to European Paediatric Neurology Society Meeting, Baden, Germany, 11 September, 2001. Eur. J. Paediatr. Neurol. 6, 293\u2013297.","DOI":"10.1053\/ejpn.2002.0612"},{"key":"10.1016\/j.neuropharm.2012.08.010_bib51","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/mrdd.10026","article-title":"Associations between MeCP2 mutations, X-chromosome inactivation, and phenotype","volume":"8","author":"Hoffbuhr","year":"2002","journal-title":"Ment. Retard. Dev. Disabil. Res. Rev."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib52","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.neulet.2005.05.056","article-title":"Defect in normal developmental increase of the brain biogenic amine concentrations in the mecp2-null mouse","volume":"386","author":"Ide","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib53","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1152\/japplphysiol.01361.2011","article-title":"7,8-dihydroxyflavone (7,8-DHF) exhibits therapeutic efficacy in a mouse model of Rett syndrome","volume":"112","author":"Johnson","year":"2012","journal-title":"J.\u00a0Appl. Physiol."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib54","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/561","article-title":"Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription","volume":"19","author":"Jones","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib55","doi-asserted-by":"crossref","first-page":"e26499","DOI":"10.1371\/journal.pone.0026499","article-title":"Generation and characterization of rat and mouse monoclonal antibodies specific for MeCP2 and their use in X-inactivation studies","volume":"6","author":"Jost","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2012.08.010_bib56","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/hmg\/ddn026","article-title":"Targeted delivery of an Mecp2 transgene to forebrain neurons improves the behavior of female Mecp2-deficient mice","volume":"17","author":"Jugloff","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib57","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1111\/j.1460-9568.2008.06305.x","article-title":"Environmental enrichment ameliorates a motor coordination deficit in a mouse model of Rett syndrome\u2013Mecp2 gene dosage effects and BDNF expression","volume":"27","author":"Kondo","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib58","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1046\/j.1365-2958.1997.4151781.x","article-title":"Molecular localization of the Escherichia coli cytotoxic necrotizing factor CNF1 cell-binding and catalytic domains","volume":"24","author":"Lemichez","year":"1997","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib59","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nature10214","article-title":"A\u00a0role for glia in the progression of Rett's syndrome","volume":"475","author":"Lioy","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.08.010_bib60","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.biopsych.2009.12.022","article-title":"Early environmental enrichment moderates the behavioral and synaptic phenotype of MeCP2 null mice","volume":"67","author":"Lonetti","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.08.010_bib61","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.neubiorev.2010.12.014","article-title":"Early-stress regulates resilience, vulnerability and experimental validity in laboratory rodents through mother-offspring hormonal transfer","volume":"35","author":"Macri","year":"2011","journal-title":"Neurosci. Biobehav Rev."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib62","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1017\/S1740925X1200004X","article-title":"Does microglial dysfunction play a role in autism and Rett syndrome?","volume":"7","author":"Maezawa","year":"2012","journal-title":"Neuron Glia Biol."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib63","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.1523\/JNEUROSCI.5966-09.2010","article-title":"Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate","volume":"30","author":"Maezawa","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib64","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1523\/JNEUROSCI.0324-09.2009","article-title":"Rett syndrome astrocytes are abnormal and spread MeCP2 deficiency through gap junctions","volume":"29","author":"Maezawa","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib65","doi-asserted-by":"crossref","first-page":"e34115","DOI":"10.1371\/journal.pone.0034115","article-title":"CNF1 improves\u00a0astrocytic ability to support neuronal growth and differentiation in vitro","volume":"7","author":"Malchiodi-Albedi","year":"2012","journal-title":"PlosOne"},{"key":"10.1016\/j.neuropharm.2012.08.010_bib66","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1093\/hmg\/ddi198","article-title":"CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome","volume":"14","author":"Mari","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib67","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1126\/science.1090842","article-title":"DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation","volume":"302","author":"Martinowich","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2012.08.010_bib68","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/npp.2011.274","article-title":"Pharmacological activation of group-II metabotropic glutamate receptors corrects a schizophrenia-like phenotype induced by prenatal stress in mice","volume":"37","author":"Matrisciano","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.08.010_bib69","doi-asserted-by":"crossref","first-page":"18267","DOI":"10.1073\/pnas.0608702103","article-title":"Enhanced anxiety and stress-induced corticosterone release are associated with increased Crh expression in a mouse model of Rett syndrome","volume":"103","author":"McGill","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.08.010_bib70","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1126\/science.1206593","article-title":"Adult neural function requires MeCP2","volume":"333","author":"McGraw","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2012.08.010_bib71","first-page":"77","article-title":"Animal models of depression: an overview","volume":"2","author":"McKinney","year":"1984","journal-title":"Psychiatr. Dev."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib72","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0149-7634(03)00069-1","article-title":"Metabolic imprinting of choline by its availability during gestation: implications for memory and attentional processing across the lifespan","volume":"27","author":"Meck","year":"2003","journal-title":"Neurosci. Biobehav Rev."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib73","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1152\/jn.00826.2007","article-title":"Early defects of GABAergic synapses in the brain stem of a MeCP2 mouse model of Rett syndrome","volume":"99","author":"Medrihan","year":"2008","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib74","doi-asserted-by":"crossref","first-page":"10444","DOI":"10.1073\/pnas.0603914103","article-title":"TrkB binds and tyrosine-phosphorylates Tiam1, leading to activation of Rac1 and induction of changes in cellular morphology","volume":"103","author":"Miyamoto","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.08.010_bib75","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/hmg\/ddi016","article-title":"Abnormalities of social interactions and home-cage behavior in a mouse model of Rett syndrome","volume":"14","author":"Moretti","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib76","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1523\/JNEUROSCI.2623-05.2006","article-title":"Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome","volume":"26","author":"Moretti","year":"2006","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib77","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/09638280150504207","article-title":"Behavioural and emotional features in Rett syndrome","volume":"23","author":"Mount","year":"2001","journal-title":"Disabil. Rehabil."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib78","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/nn.2436","article-title":"Dynamic DNA methylation programs persistent adverse effects of early-life stress","volume":"12","author":"Murgatroyd","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib79","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.nbd.2007.02.003","article-title":"Postnatal dietary choline supplementation alters behavior in a mouse model of Rett syndrome","volume":"26","author":"Nag","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib80","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.brainres.2008.08.042","article-title":"Effects of postnatal dietary choline supplementation on motor regional brain volume and growth factor expression in a mouse model of Rett syndrome","volume":"1237","author":"Nag","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib81","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.bbr.2008.07.008","article-title":"Environmental enrichment alters locomotor behaviour and ventricular volume in Mecp2 1lox mice","volume":"196","author":"Nag","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib82","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1055\/s-2007-979724","article-title":"Rett syndrome studies of natural history and search for a genetic marker","volume":"26","author":"Naidu","year":"1995","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.neuropharm.2012.08.010_bib83","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.brainres.2008.08.046","article-title":"Prenatal choline supplementation in rats increases the expression of IGF2 and its receptor IGF2R and enhances IGF2-induced acetylcholine release in hippocampus and frontal cortex","volume":"1237","author":"Napoli","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib84","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/j.1528-1167.2010.02597.x","article-title":"Epilepsy in Rett syndrome\u2013the experience of a National Rett Center","volume":"51","author":"Nissenkorn","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2012.08.010_bib85","doi-asserted-by":"crossref","first-page":"10912","DOI":"10.1523\/JNEUROSCI.1869-07.2007","article-title":"Brain-derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome","volume":"27","author":"Ogier","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib86","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1471-2202-12-47","article-title":"Biogenic amines and their metabolites are differentially affected in the Mecp2-deficient mouse brain","volume":"12","author":"Panayotis","year":"2011","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib87","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.pain.2009.06.026","article-title":"The Rac GTPase-activating bacterial protein toxin CNF1 induces analgesia up-regulating mu-opioid receptors","volume":"145","author":"Pavone","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2012.08.010_bib88","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/01.wnr.0000208995.38695.2f","article-title":"An altered neonatal behavioral phenotype in Mecp2 mutant mice","volume":"17","author":"Picker","year":"2006","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2012.08.010_bib89","unstructured":"Pobbe R.L., Pearson B.L., Blanchard D.C. and Blanchard R.J., Oxytocin receptor and Mecp2(308\/Y) knockout mice exhibit altered expression of autism-related social behaviors, Physiol. Behav, in press."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib90","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1002\/jnr.22409","article-title":"Aminoglycoside-mediated partial suppression of MECP2 nonsense mutations responsible for Rett syndrome in\u00a0vitro","volume":"88","author":"Popescu","year":"2010","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib91","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0166-2236(00)02118-4","article-title":"Rho proteins, mental retardation and the cellular basis of cognition","volume":"25","author":"Ramakers","year":"2002","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib92","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/ajmg.a.33184","article-title":"The MECP2 duplication syndrome","volume":"152A","author":"Ramocki","year":"2010","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.neuropharm.2012.08.010_bib93","first-page":"723","article-title":"On a unusual brain atrophy syndrome in hyperammonemia in childhood","volume":"116","author":"Rett","year":"1966","journal-title":"Wien Med. Wochenschr"},{"key":"10.1016\/j.neuropharm.2012.08.010_bib94","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1037\/0735-7044.112.6.1387","article-title":"Postnatal choline supplementation in preweanling mice: sexually dimorphic behavioral and neurochemical effects","volume":"112","author":"Ricceri","year":"1998","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib95","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.bbr.2011.03.051","article-title":"Cholinergic hypofunction in MeCP2-308 mice: beneficial neurobehavioural effects of neonatal choline supplementation","volume":"221","author":"Ricceri","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib96","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/FBP.0b013e32830c3645","article-title":"Mouse models of Rett syndrome: from behavioural phenotyping to preclinical evaluation of new therapeutic approaches","volume":"19","author":"Ricceri","year":"2008","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib97","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1111\/j.1460-9568.2007.05466.x","article-title":"Treatment with desipramine improves breathing and survival in a mouse model for Rett syndrome","volume":"25","author":"Roux","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib98","doi-asserted-by":"crossref","first-page":"21966","DOI":"10.1073\/pnas.0912257106","article-title":"Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalities","volume":"106","author":"Samaco","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.08.010_bib99","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/01.NT.0000286155.55343.fa","article-title":"Choline: dietary requirements and role in brain development","volume":"42","author":"Sanders","year":"2007","journal-title":"Nutr. Today"},{"key":"10.1016\/j.neuropharm.2012.08.010_bib100","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0006-8993(02)02900-1","article-title":"Prenatal choline supplementation increases NGF levels in the hippocampus and frontal cortex of young and adult rats","volume":"947","author":"Sandstrom","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib101","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1601-183X.2006.00258.x","article-title":"Evidence for abnormal early development in a mouse model of Rett syndrome","volume":"6","author":"Santos","year":"2007","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib102","unstructured":"Schaevitz, L. R., Lopez, C. M., Diddio, S., Iannoni, E., Nicolai, R., Amato, A., Berger-Sweeney, J. E., 2010a. Acetyl-carnitine improves general health in a mouse model of Rett syndrome. IBNS Annual Meeting, Villasimius, Cagliari, Italy, pp. 586\u2013592."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib103","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.physbeh.2009.12.025","article-title":"Cognitive and social functions and growth factors in a mouse model of Rett syndrome","volume":"100","author":"Schaevitz","year":"2010","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib104","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1523\/JNEUROSCI.0865-11.2012","article-title":"A\u00a0TrkB small molecule partial agonist rescues TrkB phosphorylation deficits and improves respiratory function in a mouse model of Rett syndrome","volume":"32","author":"Schmid","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib105","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/42735","article-title":"Gln 63 of Rho is deamidated by Escherichia coli cytotoxic necrotizing factor-1","volume":"387","author":"Schmidt","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.08.010_bib106","doi-asserted-by":"crossref","first-page":"13669","DOI":"10.1074\/jbc.273.22.13669","article-title":"The Rho-deamidating cytotoxic necrotizing factor 1 from Escherichia coli possesses transglutaminase activity. Cysteine 866 and histidine 881 are essential for enzyme activity","volume":"273","author":"Schmidt","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib107","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0896-6273(02)00768-7","article-title":"Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3","volume":"35","author":"Shahbazian","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2012.08.010_bib108","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.neuroscience.2007.02.009","article-title":"Behavioral and anatomical abnormalities in Mecp2 mutant mice: a model for Rett syndrome","volume":"146","author":"Stearns","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2012.08.010_bib109","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1113\/jphysiol.2006.119966","article-title":"Breathing dysfunctions associated with impaired control of postinspiratory activity in Mecp2-\/y knockout mice","volume":"579","author":"Stettner","year":"2007","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib110","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1111\/j.1460-9568.2006.05129.x","article-title":"Corticotropin-releasing factor promotes growth of brain norepinephrine neuronal processes through Rho GTPase regulators of the actin cytoskeleton in rat","volume":"24","author":"Swinny","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib111","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1073\/pnas.0812394106","article-title":"Partial reversal of Rett syndrome-like symptoms in MeCP2 mutant mice","volume":"106","author":"Tropea","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.08.010_bib112","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0079-6123(04)47022-8","article-title":"Rho proteins, mental retardation and the neurobiological basis of intelligence","volume":"147","author":"van Galen","year":"2005","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib113","doi-asserted-by":"crossref","first-page":"e20733","DOI":"10.1371\/journal.pone.0020733","article-title":"Ex\u00a0vivo treatment with a novel synthetic aminoglycoside NB54 in primary fibroblasts from Rett syndrome patients suppresses MECP2 nonsense mutations","volume":"6","author":"Vecsler","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2012.08.010_bib114","doi-asserted-by":"crossref","first-page":"11521","DOI":"10.1523\/JNEUROSCI.4373-05.2005","article-title":"Mecp2 deficiency disrupts norepinephrine and respiratory systems in mice","volume":"25","author":"Viemari","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib115","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1471-4159.2008.05768.x","article-title":"Neurochemical changes in a mouse model of Rett syndrome: changes over time and in response to perinatal choline nutritional supplementation","volume":"108","author":"Ward","year":"2009","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib116","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.neuroscience.2011.01.061","article-title":"Synaptic plasticity deficits in an experimental model of Rett syndrome: long-term potentiation saturation and its pharmacological reversal","volume":"180","author":"Weng","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2012.08.010_bib117","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1055\/s-2007-973476","article-title":"Altered cholinergic function in the basal forebrain of girls with Rett syndrome","volume":"30","author":"Wenk","year":"1999","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.neuropharm.2012.08.010_bib118","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.nbd.2008.01.008","article-title":"Prenatal choline supplementation attenuates neuropathological response to status epilepticus in the adult rat hippocampus","volume":"30","author":"Wong-Goodrich","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2012.08.010_bib119","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.resp.2007.08.009","article-title":"Oral treatment with desipramine improves breathing and life span in Rett syndrome mouse model","volume":"160","author":"Zanella","year":"2008","journal-title":"Respir. Physiol. Neurobiol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812004467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812004467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T17:08:13Z","timestamp":1714324093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390812004467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":119,"alternative-id":["S0028390812004467"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2012.08.010","relation":{},"ISSN":["0028-3908"],"issn-type":[{"type":"print","value":"0028-3908"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}